When I use a word . . . Seeding trials

Gambleaware: what does “independence” from industry really mean?

Breaking barriers and building bridges: reimagining a feminist health workforce

The problem with Silicon Valley medicine

The dearth of disaggregated health data: a political rather than a technical challenge

In the US, patient data privacy is an illusion

Tom Nolan’s research reviews—1 June 2023

Safeguarding NICE from patient groups’ conflicts of interest

Lost your identity at medical school? Try doing something different

When I use a word . . . Commercial clinical trials